UVADEX (Therakos, Inc.)


Welcome to the PulseAid listing for the UVADEX drug offered from Therakos, Inc.. This Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE],Psoralen [EPC],Psoralens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Therakos, Inc.
NON-PROPRIETARY NAME: Methoxsalen
SUBSTANCE NAME: METHOXSALEN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE],Psoralen [EPC],Psoralens [Chemical/Ingredient]
ROUTE: EXTRACORPOREAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1999-02-25
END MARKETING DATE: 0000-00-00


UVADEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUVADEX from Therakos, Inc.
LABELER NAME: Therakos, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(ug/mL)
START MARKETING DATE: 1999-02-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64067-216_5af4d480-484b-4303-92ed-963a614fe09b
PRODUCT NDC: 64067-216
APPLICATION NUMBER: NDA020969

Other METHOXSALEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Methoxsalen
Oceanside PharmaceuticalsMethoxsalen
Strides Shasun LimitedMethoxsalen
Therakos, Inc.UVADEX
Valeant Pharmaceuticals North America LLCOxsoralen-Ultra